Skip to content
value.today

CV Sciences, Inc. vs Johnson & Johnson

Add a company

Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.

In short

  • Johnson & Johnson is the larger company by market value: $652.5 B against $20 M for CV Sciences, Inc., 32624 times as much (market caps of Jan 7, 2022 for CV Sciences, Inc. and Oct 29, 2026 for Johnson & Johnson). CV Sciences, Inc.'s value is the last on file, from Jan 7, 2022: no market-data feed is connected for its exchange yet.
  • Johnson & Johnson had more revenue: $94.2 B against $14 M for CV Sciences, Inc., both in the year to December 2025.
  • Johnson & Johnson made a net profit of $26.8 B, while CV Sciences, Inc. made a net loss of $1 M.
  • Johnson & Johnson keeps more of each dollar of sales: a net margin of 28.5% against -7.0% for CV Sciences, Inc.
  • Johnson & Johnson employs more people: 138,200 against 44 at CV Sciences, Inc. Each employee brings in about $313,409 of revenue at CV Sciences, Inc. and $681,570 at Johnson & Johnson.

Market value, the same start = 100

From Jan 2020: how each one's value moved, whatever its size.

043851281702020202120222023202420252026CV Sciences, Inc. 19Johnson & Johnson 170

Revenue by fiscal year

US$ billions, as reported in each year's annual results.

$0B$24B$47B$71B$94B201720182019202020212022202320242025CV Sciences, Inc. $0BJohnson & Johnson $94B

Side by side

Side-by-side comparison; ▲ marks the best value of a measure where higher or lower is better
MeasureCV Sciences, Inc.
CVSI
Johnson & Johnson
JNJ · #23 in the world
Profile
Country🇺🇸 USA🇺🇸 USA
SectorHealthcareHealthcare
IndustryPharmaceuticalPharmaceutical
Founded20101886
Size
Market cap$20 M*$652.5 B
Revenue$14 M$94.2 B
Net income$-1 M$26.8 B▲ best
Employees44138,200
Valuation
P/E ratio—40.5×
Price to sales—6.6×
Price to book—8.0×
Free cash flow yield—3.0%
Profitability
Gross margin49.0%—
Operating margin-3.4%—
Net margin-7.0%—
Return on equity-58.7%—
Growth
Revenue growth-12.2%—
Revenue growth, 3 years a year-5.2%—
Financial strength
Debt to equity1.1×—
Cash
Free cash flow margin-3.8%—
Strength scores
Piotroski F-score6 of 9—
Altman Z-score zone——
Data as ofMarket cap Jan 2022; ratios FY2025Market cap Oct 2026

▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither

Questions and answers#

Which is bigger, CV Sciences, Inc. or Johnson & Johnson?

Johnson & Johnson is the larger company by market value: $652.5 B against $20 M for CV Sciences, Inc., 32624 times as much (market caps of Jan 7, 2022 for CV Sciences, Inc. and Oct 29, 2026 for Johnson & Johnson). CV Sciences, Inc.'s value is the last on file, from Jan 7, 2022: no market-data feed is connected for its exchange yet.

Which makes more money, CV Sciences, Inc. or Johnson & Johnson?

Johnson & Johnson had more revenue: $94.2 B against $14 M for CV Sciences, Inc., both in the year to December 2025. Johnson & Johnson made a net profit of $26.8 B, while CV Sciences, Inc. made a net loss of $1 M.

Which is more profitable, CV Sciences, Inc. or Johnson & Johnson?

Johnson & Johnson keeps more of each dollar of sales: a net margin of 28.5% against -7.0% for CV Sciences, Inc.

Which has more employees, CV Sciences, Inc. or Johnson & Johnson?

Johnson & Johnson employs more people: 138,200 against 44 at CV Sciences, Inc. Each employee brings in about $313,409 of revenue at CV Sciences, Inc. and $681,570 at Johnson & Johnson.

Sources#

Every figure on this page comes from these, with the date shown next to it.